LuMind IDSC statement on FDA Advisory Committee for promising Alzheimer’s drug, donanemab
LuMind IDSC is encouraged by today’s news that the U.S. Food and Drug Administration (FDA) is requesting more time and
March 8, 2024
LuMind IDSC is encouraged by today’s news that the U.S. Food and Drug Administration (FDA) is requesting more time and
Medicare, Medicaid and Dual Enrollment for Adults with IDD Boston University School of Public Health recently published an article in
“I want to enjoy my life for a long time. I want to grow old just like everyone else.” These
Thanks to the extraordinary support and engagement of the Down syndrome community, LuMind IDSC is celebrating a year of outstanding
Individuals with Down syndrome are among those most at risk of disparities, and Black individuals with Down syndrome might be
Hampus Hillerstrom, CEO of LuMind IDSC Foundation and father to a child with Down syndrome, knows about the barriers people
Tuesday, September 26, 2023 NIH designates people with disabilities as a population with health disparities Designation, new research program and
Down syndrome leader Christina Reaves will lead community programs for LuMind IDSC Following a five-month, national search, LuMind IDSC Down
LuMind IDSC and The Arc of Northeast collaborated on an OpEd that was recently published in The Boston Globe. Authors
Medicaid Enrollment and Service Use Among Adults with Down Syndrome September 16, 2023 In a recently published study in the